Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03001934

Super Chinese Nephrotic Syndrome Registration System (SUCCESS)

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

The investigators are registering all nephrotic syndrome (NS) patients regardless of the primary causes and developing a NS database in China. Patients will be followed-up and both baseline and follow-up information will be recorded in the registration system. The treatment response, longitudinal changes of renal function, renal survival, patient survival, infection events and acute kidney injury etc, will be analyzed using the NS database.

Detailed description

The investigators are registering all NS patients regardless of the primary causes in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and education), clinical characteristics (including systolic blood pressure, diastolic blood pressure, primary cause of NS, and lab measurements of serum, urine), pathological characteristics, treatment and treatment response, complications and outcomes. Patients will be followed up, the demographic, clinical characteristics, treatment, lab tests of blood and urine and complications of patients will be collected and recorded at each visit. The investigators also record the outcome at each visit, such as treatment response, longitudinal changes of renal function, hospitalization, occurrence of infection or cardiovascular events etc. The outcomes will be analyzed using the NS database.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionRegistration of all NS patients in the First Affiliated Hospital of Sun Yat-sen University and other hospitals which have signed the contract in China.

Timeline

Start date
2016-04-01
Primary completion
2026-12-01
Completion
2028-12-01
First posted
2016-12-23
Last updated
2020-10-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03001934. Inclusion in this directory is not an endorsement.